Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STP938 in Relapsed/Refractory B-Cell and T-Cell Lymphomas
NCT05463263Phase 2Recruiting
- Sponsor
- StepPharma
- Start
- Aug 2022
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of dencatistat in B cell lymphoma, T-cell lymphoma, sponsored by StepPharma. Started Aug 2022; status: recruiting.
02
Drugs
dencatistat
03
Conditions
B cell lymphomaT-cell lymphoma
Beyond the preview
Go deeper on NCT05463263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05463263.